Health Care & Life Sciences » Healthcare Provision | Sapporo Clinical Laboratory Inc.

Sapporo Clinical Laboratory Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
16,550
17,166
17,528
17,055
17,460
Cost of Goods Sold (COGS) incl. D&A
11,830
12,164
12,396
12,097
12,214
Gross Income
4,720
5,003
5,133
4,958
5,246
SG&A Expense
3,814
4,133
4,158
3,694
3,731
EBIT
906
870
974
783
1,020
Unusual Expense
-
79
-
44
53
Non Operating Income/Expense
28
27
20
17
33
Interest Expense
4
2
2
2
2
Pretax Income
853
896
950
746
1,052
Income Tax
359
322
359
232
367
Consolidated Net Income
494
574
591
514
685
Net Income
494
574
591
514
685
Net Income After Extraordinaries
494
574
591
514
685
Net Income Available to Common
494
574
591
514
685
EPS (Basic)
124.12
150.98
169.75
147.71
197.04
Basic Shares Outstanding
4
4
3
3
3
EPS (Diluted)
124.14
150.98
169.75
147.71
197.04
Diluted Shares Outstanding
4
4
3
3
3
EBITDA
1,245
1,204
1,277
1,116
1,362
Other Operating Expense
-
-
-
481
495
Non-Operating Interest Income
2
2
1
1
1

About Sapporo Clinical Laboratory

View Profile
Address
18-9-1 Nishi, Kita 5-Jo
Sapporo Hokkaido 060
Japan
Employees -
Website http://www.saturin.co.jp
Updated 09/14/2018
Sapporo Clinical Laboratory Inc. engages in the clinical testing business for the medical industry. It operates through the following segments: Clinical Testing, Dispensing Pharmacy, Medical Equipment Sales and Maintenance, and Others. The Clinical Testing segment provides contract laboratory tests necessary for medical institutions.